Loomis, Sayles and »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Loomis, Sayles and

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Loomis, Sayles and from 13F filings

Historical chart of Loomis, Sayles and investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Loomis, Sayles and consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Loomis, Sayles and

Quarter filed Position value Share count Share price at filing
2025-09-30 $262k 3.6k 73.35
2025-06-30 $186k 3.6k 52.02
2025-03-31 $228k 3.6k 63.87

More positions owned by Loomis, Sayles and

Nvidia Corp Common (NVDA)
Tesla Common (TSLA)
Meta Platforms Common (META)
Oracle Corp Common (ORCL)
Netflix.com Common (NFLX)
Alphabet Inc-cl A Common (GOOGL)
Amazon.com Common (AMZN)
Visa Inc-class A Shrs Common (V)
Microsoft Corp Common (MSFT)
Boeing Common (BA)
Shopify Inc - Class A Common (SHOP)
Autodesk Common (ADSK)
Monster Beverage Corporation Common (MNST)
The Walt Disney Common (DIS)
Vertex Pharmaceuticals Common (VRTX)

View all positions for Loomis, Sayles and

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1